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Abstract Eye pain is an unpleasant sensory and emo-
tional experience including sensory-discriminative, emo-
tional, cognitive, and behavioral components and
supported by distinct, interconnected peripheral and central
nervous system elements. Normal or physiological pain
results of the stimulation by noxious stimuli of sensory
axons of trigeminal ganglion (TG) neurons innervating the
eye. These are functionally heterogeneous. Mechano-no-
ciceptors are only excited by noxious mechanical forces.
Polymodal nociceptors also respond to heat, exogenous
irritants, and endogenous inflammatory mediators, whereas
cold thermoreceptors detect moderate temperature changes.
Their distinct sensitivity to stimulating forces is determined
by the expression of specific classes of ion channels:
Piezo2 for mechanical forces, TRPV1 and TRPA1 for heat
and chemical agents, and TRPM8 for cold. Pricking pain is
evoked by mechano-nociceptors, while polymodal noci-
ceptors are responsible of burning and stinging eye pain;
sensations of dryness appear to be mainly evoked by cold
thermoreceptors. Mediators released by local inflammation,
increase the excitability of eye polymodal nociceptors
causing their sensitization and the augmented pain sensa-
tions. During chronic inflammation, additional, long-
lasting changes in the expression and function of stimulus-
transducing and voltage-sensitive ion channels develop,
thereby altering polymodal terminal’s excitability and
evoking chronic inflammatory pain. When trauma, infec-
tions, or metabolic processes directly damage eye nerve
terminals, these display aberrant impulse firing due to an
abnormal expression of transducing and excitability-
modulating ion channels. This malfunction evokes ‘neu-
ropathic pain’ which may also result from abnormal
function of higher brain structures where ocular TG neu-
rons project. Eye diseases or ocular surface surgery cause
different levels of inflammation and/or nerve injury, which
in turn activate sensory fibers of the eye in a variable de-
gree. When inflammation dominates (allergic or actinic
kerato-conjunctivitis), polymodal nociceptors are primarily
stimulated and sensitized, causing pain. In uncomplicated
photorefractive surgery and moderate dry eye, cold ther-
moreceptors appear to be mainly affected, evoking pre-
dominant sensations of unpleasant dryness.
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Introduction
Pain has been defined as ‘‘an unpleasant sensory and
emotional experience associated with actual or potential
tissue damage, or described in terms of such damage’’ [1].
In the eye, diseases leading to impaired vision such as
cataract, retinal detachment or degeneration, or open-angle
glaucoma course without pain, in spite of the accompa-
nying damage to important eye structures. Nevertheless,
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pain is a symptom in a variety of other ocular pathologies,
in particular those affecting tissues of the anterior segment
of the eyeball and the orbit. The growing number of eye
surface manipulations in the clinics (surgery, contact
lenses) and the frequent exposure to artificial environments
(air conditioning, video display terminals, air pollutants) is
renewing the interest of eye care professionals for a better
understanding of ocular pain [2••].
The qualitative and quantitative components of the pain
experience vary, reflecting the complexity of the underly-
ing peripheral and central neural processes. Sensory-dis-
criminative nervous mechanisms map the origins of
damaging events (mechanical, chemical, thermal) along
with their location, their intensity and temporal aspects of
the experience. The affective-motivational neural
mechanisms of pain produce the accompanying emotional
distress, which may have different quality and intensity.
They have a compelling arousing and directive nature,
comprising reflex responses, and complex behavioral re-
actions. Processing of the sensory-discriminative and af-
fective-motivational features of pain is performed along the
brainstem and multiple upper brain structures. These are
subjected to intrinsic control by cortical, subcortical, and
midbrain modulatory networks. Hence, the pain experience
constitutes a highly distributed and complex brain function
[3, 4].
Physiological or Nociceptive Pain
The most obvious origin of eye pain is acute local injury.
External physical or chemical stimuli acting on the eye at
intensities near or over the level required to cause cell
damage, stimulate a specific set of peripheral sensory nerve
fibers generically named nociceptors [5]. These produce a
discharge of nerve impulses that travel to the brain, en-
coding the spatial, and temporal characteristics of the
noxious stimuli [6]. This sensory information is processed
at various levels of the neuroaxis, finally reaching different
areas of the cerebral cortex where it evokes pain sensations
and unpleasant feelings referred to the eye, which persist
for a variable period of time until healing takes place [7].
Such schematic description corresponds to the so-called
‘‘normal, physiological or nociceptive pain’’ an evolu-
tionarily old mechanism aimed at protecting tissues from
immediate potential or actual damage and promoting
healing mechanisms, immobility, and rest [8]. Acute pain
additionally triggers a number of stereotyped defensive
responses that in the case of the eye includes reflex
blinking and tearing, protective motor behavior (eye clo-
sure, head withdrawal, rubbing of the eye), and verbal
expressive behavior [2••]. Hence, nociceptive pain alerts
the organism of potential injury and due to its intrinsic and
aversive nature, constitutes a well-defined, ancestral pro-
tection mechanism.
Peripheral Origin
Nociceptors are peripheral sensory fibers acting as specific
detectors for injurious stimuli [6]. They do not constitute a
morphologically and functionally homogeneous population
[9, 10]. In the eyeball, a fraction of them respond exclusively
to noxious mechanical forces and are called mechano-noci-
ceptors [11••]. The majority is also excited by mechanical
stimuli and additionally respond to heat ([40 C) and to a
large variety of exogenous irritant chemicals, bacterial toxins,
and endogenous inflammatory substances, being appropri-
ately named polymodal nociceptors [11••, 12••, 13••]. Unlike
the skin and non-keratinized surface mucosae, the eye surface
does not receive the rich variety of low-threshold
mechanoreceptor fibers that sustain cutaneous tactile sensi-
tivity, although some low-threshold mechanoreceptors have
been incidentally reported in the conjunctiva [14] and they are
abundant in the lids, including palpebral conjunctiva. How-
ever, the eye surface is innervated by cold thermoreceptor
fibers that extend into the cornea, limbus, and bulbar con-
junctiva, and are sensitive to temperature drops [13••]. The
majority of these cold thermoreceptor fibers are functionally
similar to the canonical low-threshold cold thermoreceptors of
the skin and themucosae ofmouth, tongue, andnose [15]; they
exhibit a continuous impulse activity at the background tissue
temperature, which increases prominently with small tem-
perature drops [13••, 16, 17]. A reduced subset of cold-sen-
sitive fibers does not exhibit spontaneous activity at
background temperature and fire nerve impulses only when
strong cooling is applied to the corneal surface [13••, 18].
Conceivably, these high-threshold cold receptors can be
functionally classified as a particular subtype of nociceptors
[19]. Each functional class of eye sensory nerve fiber evokes a
particular modality of conscious sensation [20••, 21•].
Central Representation
The cell somata of the sensory neurons innervating the eye
surface, which are located in the TG, are heterogeneous not
only in the above-described transducing properties of the
endings, but also in size, molecular signature, and active
and passive membrane properties [22, 23]. Their central
axons terminate in two regions of the trigeminal brainstem
complex, the trigeminal subnucleus interpolaris/caudalis
transition region (Vi/Vc) and the caudalis/upper cervical
cord junction (Vc/C1) [24•, 25] establishing direct or in-
terneuron-mediated contacts with second-order projection
ocular neurons [26••, 27••]. These, in turn, project prefer-
entially to the parabrachial nucleus [28] and also to the
posterior thalamus [29] and the insular cortex to convey
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information associated to the sensory-discriminative
aspects of pain, and to the periaqueductal gray, hypotha-
lamus, amygdala, and prefrontal cortex for the emotional
aspects of pain [30]. Axons of second-order eye neurons
primarily located in Vi/Vc, project to other brain areas
involved in lacrimation (superior salivatory nucleus) and
eyeblink (facial motor nucleus).
Modulation
Strong physical or chemical actions on eye surface tissues
destroy in a variable degree corneal and/or conjunctival
cells. Inflammation results of the local release of a large
variety of chemicals by injured local cells and by resident
or migrating immune cells (epithelium cells, fibroblasts,
mast cells, neutrophils, monocytes, platelets) [9]. Released
chemical agents include among others H?, ATP and ade-
nosine, protons, prostaglandins and leukotrienes,
bradykinin, 5HT, platelet-activating factor, histamine, as
well as cytokines such as interleukins and tumor necrosis
factor and neurotrophins, like NGF [2••]. In addition, di-
rectly stimulated nociceptor nerve terminals release locally
neuropeptides (Substance P, CGRP, Neurokinin A) [31].
Distant intact branches of the same parent axon become
also depolarized by antidromic propagation of nerve im-
pulses, thereby extending neuropeptide release to intact
tissue areas. Neuropeptides further potentiate the liberation
of mediators by inflammatory cells [32]. Inflammatory
mediators evoke spontaneous impulse activity in nocicep-
tor terminals, lowering of the stimulus threshold, and
augmenting nerve impulse discharge generated by
suprathreshold stimulation [9, 33]. These changes are
jointly named ‘peripheral sensitization’ [34, 35]. Sensiti-
zation leads to spontaneous pain to allodynia, i.e., pain
evoked by mechanical or thermal stimuli of innocuous
intensities and to hyperalgesia, as it is named the exag-
gerated pain caused by mild noxious stimuli in the primary
area of inflammation [1]. Hence, peripheral nociceptor
sensitization is responsible of the distinct quality and per-
sistence of pain arising from inflamed tissues.
Neuropathic Pain
In certain circumstances, pain is not the result of a pe-
ripheral insult to the innervated tissue, but is caused by a
direct injury or functional disturbance of the neural ele-
ments involved in the detection and processing of noci-
ceptive stimuli [36, 37]. These elements include the
peripheral nerve terminals and axons of the nociceptive
sensory neurons located in the dorsal root and cephalic
sensory ganglia; they also comprise the higher-order neu-
rons of the spinal cord, brain stem, thalamus, and various
other subcortical and cortical structures in charge of re-
ceiving and processing the peripheral nociceptive input.
The abnormal, unpleasant sensation caused by the dis-
turbed functioning of any of the components of the brain
pain matrix is called ‘neuropathic pain’ [1] and is typically
evoked at the periphery by sensory nerve traumatisms,
metabolic diseases as diabetes, and by the action of a large
variety of chemical, toxic, or infectious agents causing
damage to peripheral sensory neurons at any point of their
trajectory (peripheral neuropathic pain); within the central
nervous system, damage to the pain-processing neuronal
groups composing the pain network by ischemia, hemor-
rhage, mechanical compression, infections, or degenerative
processes may also lead to central neuropathic pain.
Transduction Mechanisms in Eye Nociceptors
Sensory nerve terminals innervating the eye are peripheral
axons of neurons located in the trigeminal ganglion. These
manufacture in their cell body different ion channel-
transducing proteins that are transported to the peripheral
endings. Transducing channels open when stimulated by a
specific form of energy, thereby causing depolarization and
a nerve impulse discharge that conveys sensory informa-
tion to the brain. The specific sensitivity of each neuronal
class to a given physical or chemical energy change is
determined, at the molecular level, by the distinct expres-
sion in each ocular TG neuron class of different ion
channel-transducing proteins. In addition, TG neurons ex-
press voltage-gated sodium (Nav), potassium (Kv) and
calcium (Cav) ion channels, and ligand-gated channels, like
hyperpolarization-gated cyclic nucleotide (HCN) channels
that contribute to shape the final neuronal excitability, and
are critical to modulate the frequency and firing pattern of
nerve impulses generated at the peripheral sensory termi-
nals in the ocular tissues [38•].
With the use of cytochemical, biophysical, and phar-
macological tools, several classes of transducing channels
have been identified in the aforementioned functional types
of eye TG neurons. Transduction of mechanical forces by
corneal mechano-nociceptor and perhaps, also polymodal
nociceptor neuron endings is possibly mediated by Piezo2,
a mechanosensory channel recently identified in low-
threshold somatic mechanoreceptor neurons [39••]. Poly-
modal neurons, preferentially those that contain neu-
ropeptides, also express the heat and proton-sensitive
TRPV1 channel, which is additionally the main final target
for several of the signaling pathways activated by mem-
brane receptor proteins for inflammatory mediators [40,
41••, 42•, 43]. Eye polymodal nociceptor TG neurons in
particular of the non-peptidergic subtype, also express
TRPA1, an ion channel opened by exogenous irritant
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chemicals, strong cold, and endogenous agents such as
reactive oxygen species and lipid peroxidation products
[44–46]. As occurs with TRPV1, TRPA1 is activated, or
sensitized downstream of inflammatory PLC-coupled re-
ceptor pathways by pro-inflammatory exogenous and en-
dogenous agents, thereby mediating inflammatory pain
sensitization as TRPV1 also does. Hence, these two
channel classes appear to be the main detectors of many
different irritants, endogenous chemicals, and heat [47, 48].
ASICs channels, another family of ion channels highly
sensitive to acid, have been also recently identified in
corneal polymodal neurons [49].
For temperature detection, TRPM8 channels appear to
be critical in the sensing of temperature decreases by ocular
cold thermoreceptor fibers [50•, 51•, 52•, 53]. Genetic ab-
lation of this channel in mice renders cold thermoreceptor
endings of the cornea silent and irresponsive to cooling
[41••]. TRPM8 activity is also influenced by discrete os-
molality changes, so that small increases in osmolality
augment by this mechanism cold thermoreceptor activity in
the eye [54••, 55]. Finally, background potassium channels
like the K2P channels, which stay open at basal tissue
temperature act also as thermosensor channels because
they get closed by cooling, thereby inducing depolarization
and nerve impulse firing in cold thermoreceptors [56•, 57•].
As a general rule, sensory receptor neurons tuned to re-
spond to modalities other than cold, counteract the un-
specific depolarizing effects of exposure to low
temperatures through the expression of another particular
type of cold-sensitive potassium channel (Kv1) whose ion
current named IKD opposes depolarization, thereby making
them insensitive to temperature reductions [58, 59]. Vari-
able expression of this same ‘break’ Kv1 channels serves in
canonical cold thermoreceptor neurons to finely adjust their
threshold; low-threshold cold thermoreceptors which ex-
press abundantly TRPM8 channels have a low expression
of Kv1 channels, whereas high-threshold cold thermore-
ceptors exhibiting lower levels of TRPM8, also have a
higher expression of Kv1 ‘breaking’ channels and of the
temperature-insensitive, K2P leak potassium channel
TASK-3, altogether requiring more cooling to be activated
[38•, 58, 60••, 61].
Finally, a fraction of the TG neurons classified as no-
ciceptors according to their neurochemical profile, contains
low levels of TRPM8 channels, allowing them to fire in
response to very strong cooling. In a part of these high-
threshold thermosensitive neurons, expression of Kv7.6
modulates the depolarization initiated by TRPM8 channels
[62]. Figure 1 represents schematically the types of TG
sensory neurons innervating the eye surface with their main
transducing channels and the sensations possibly evoked by
their activation.
Pathobiological Modulation of Eye Sensory Fibers
Activity in sensory nerve fibers innervating the eye expe-
rience changes in various pathologies affecting the eye.
Functional and morphological alterations of peripheral
ocular fibers are due to inflammation and/or direct pe-
ripheral or central neuronal injury, two pathobiological
processes accompanying eye diseases.
Inflammation
Noxious stimuli not only activate directly nociceptors to
evoke pain but in most cases, also cause tissue injury which
leads to local inflammation. When inflammation occurs,
the matching between the stimulus and the sensation of
pain disappears. There is ongoing pain and tenderness of
the tissue and the pain experienced under these circum-
stances is named ‘inflammatory pain.’
Inflammatory mediators locally released in eye tissues
following injury or infection, diffuse to polymodal noci-
ceptor nerve terminals where they interact with specific
membrane receptor proteins (ligand-gated ion channels,
G-protein-coupled receptors, cytokine receptors) [34]. The
inflammatory agents open membrane ion channels, either
acting directly on them or through activation of intracel-
lular signaling cascades that phosphorylate and open
TRPV1 and TRPA1 channels, causing membrane depo-
larization [63]. When this depolarization reaches the firing
threshold, a discharge of propagated nerve impulses is
generated; if the membrane potential remains below
threshold, terminals become more excitable to subsequent
stimuli, i.e., nociceptor endings are sensitized [64]. Nota-
bly, in intact cold thermoreceptors, inflammatory mediators
such as bradykinin, prostaglandins, and histamine inhibit
TRPM8 but do not do this through the conventional cell
signaling pathways; the G-protein subunit Gqa instead
binds to TRPM8 and when activated by a Gq-coupled re-
ceptor, directly inhibits ion channel activity [65••]. As a
consequence, ongoing and cold-evoked impulse activity in
cold thermoreceptors of the eye surface is reduced.
Inflammatory agents released by injury have other more
permanent effects. When they activate intracellular kinases
via their cognate receptors on the nociceptor terminals, they
also produce posttranslational changes in transducer and
voltage-gated ion channels. Consequently, the type, number,
and distribution on ion channels manufactured by the neuron
are modified. For instance, PKA activators promote the
trafficking and increased insertion of Nav1.8 and Nav1.9
sodium channels into the plasma membrane, leading to al-
tered thresholds and disturbed dynamic properties of the
nerve membrane. Changes in the expression of potassium
(Kv), calcium (Cav), and hyperpolarizing cyclic nucleotide-
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gated channels (HCN) further contribute to alter nociceptor
nerve endings excitability [66, 67•, 68, 69]. This modified
ion channel expression consolidates the spontaneous activity
which underlies persisting pain sensations and the allodynia
and hyperalgesia accompanying chronic inflammation.
The augmented nociceptor activity arising at peripheral
sensory eye neurons of the TG travels centripetally to the
trigeminal complex nuclei in the upper cervical spinal
cord–brain stem area. This sustained nociceptor input not
only generate pain, but also a phenomenon named ‘central
sensitization’ [70]. This is defined as a long-lasting homo-
and heterosynaptic facilitation of the transmission between
central axonal branches of TG neurons and the projection
neurons in the brainstem trigeminal complex, whereby the
sustained input from nociceptor fibers enables subsequent
facilitation of the response of these projection neurons [71–
73]. Central sensitization is produced by nociceptors be-
cause these are the only peripheral fibers that co-release
glutamate and neuropeptides. The combination of both
neurotransmitters acting on postsynaptic glutamate recep-
tors NMDA and AMPA, and on Substance P receptor NK1,
determines the release within the projection neurons of
sufficient intracellular calcium to increase postsynaptic
membrane excitability [7]. Central sensitization causes
secondary hyperalgesia and allodynia, thus contributing to
enhance inflammatory pain.
Nerve Injury
Lesion of peripheral nerve branches in the eye may occur
directly, by physical damage, metabolic, toxic or viral
neuropathy, or being part of an ocular tissue injury af-
fecting also other non-neural local cell types and leading to
inflammation.
When parent sensory axons and/or their terminal nerve
branches are cut or destroyed, as occurswith surgical incisions
performed for cataract, retinal detachment interventions, or
photorefractive surgery, local inflammation is transient and of
limited importance and nerve damage is the main adverse
consequence of the trauma. The immediate, main functional
effect of nerve division is the loss of sensitivity in the dener-
vated territory, which may persist for days or months de-
pending on the number of nerve branches affected and the
location of the injury along the nerve trajectory (scleral nerve
trunks, corneal stroma and sub-basal nerve branches, epithe-
lial terminals) [74, 75••, 76•].Transected axons rapidly seal off
their central terminal stump, forming a terminal swelling from
which fine branches (sprouts) begin to appear, growing
rapidly into the denervated tissue to re-establish its innerva-
tion and tissue sensitivity [77•]. However, this process gen-
erally has a limited success and recovery of innervation
density may be only partial; in the worst cases, blockade of
growth of a fraction of the injured axonsmay lead to a tangled
mass of aborted sprouts and end bulbs, forming microneuro-
mas that may coexist with successfully regenerating fibers
running in parallel [74]. Regeneration implies a very active
structural and molecular reorganization of the injured eye
neurons. Loss of nerve terminals impairs the capacity of the
parent axons to transduce the stimulating energy, thereby
decreasing their sensibility to natural stimuli; on the other
hand, receptor molecules and ion channels follow the an-
terograde axonal transport to the sprouts of the regenerating
nerve fibers, wherein they accumulate and are incorporated
into the cell membrane. Nerve damage favors altered ex-
pression, posttranslational modification, and trafficking of
transducing channels like TRPV1, TRPA1, or TRPM8 [78–
80], of Nav, Cav, and HCN channels, while the expression of
background K2P and Kv channels is down-regulated [66, 67•,
68, 69]. The drastic changes in expression, distribution, and
phosphorylation ofmany ion channels in sensory neurons lead
to modification of the intrinsic membrane properties, depo-
larization and generation of membrane potential oscillations
resulting in abnormal nerve impulse bursts in the absence of a
stimulus. This aberrant nerve activity is named ‘ectopic’ be-
cause instead of originating at the transducing terminals, it
appears at the peripheral microneuromas that become abnor-
mally sensitive tomechanical and chemical stimuli, including
pH changes. These phenomena have been demonstrated in
nociceptor fibers of various animalmodels of peripheral nerve
injury [36, 81]. Changes derived from peripheral nerve injury
Fig. 1 Schematic representation of the functional types of sensory
neurons innervating the ocular surface and the main types of
transducing channels expressed by their peripheral nerve terminals.
The specific stimuli activating each neuronal class and the quality of
sensations evoked by their activation in represented on the right side
of the figure. The qualitative sensations attributed to each functional
class of neuron is indicated on the left side. LT Low-threshold cold
thermoreceptors, HT high-threshold cold thermoreceptors. Modified
from: Belmonte C, Viana F. (Ref. [61])
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are not limited to the affected nerve axons. Certain neuro-
pathic pain states that result from peripheral nerve injury are
accompaniedbyabnormalhyperexcitability of neuronswithin
sensory ganglia [82], mediated by a glial reaction and local
inflammation that give rise to cross excitation among neigh-
boring TG sensory neurons [83].
The altered afferent input arriving from injured eye no-
ciceptor neurons reaches the projection neurons of the tri-
geminal nuclear complex and produces central sensitization
and enhanced pain [84]. When this central sensitization is
caused only by an enhanced incoming nociceptor activity,
healing reverses the phenomenon. However, after nerve in-
jury, myelinated low-threshold mechanoreceptor and cold
thermoreceptors fibers traveling in the injured nerve may
undergo phenotypic changes, including increased expression
of neuropeptides. They thus acquire the capacity to trigger or
maintain central sensitization by acting on the nociceptor
projection neurons that receive also an input from low-
threshold receptors, thereby perpetuating pain and dyses-
thesias evoked by innocuous mechanical and thermal stim-
uli. Again, such spontaneous and abnormally triggered pain
can paradoxically coexist with a reduced sensibility to nat-
ural stimuli due to the disturbed transducing capacity of the
peripheral endings of injured eye nerve fibers [85•]. Altered
neuronal excitability may be moderate and transient, ceasing
when nerve regeneration is complete. However, in some
cases, the distorted neuronal excitability persists after ap-
parent healing of the injured tissue and neuropathic pain
becomes a permanent problem [85•, 86].
Peripheral Pain Mechanisms in Kerato-
Conjunctivitis, Dry Eye Disease, Post-
photorefractive Surgery, and Contact Lens
Wearing
Ocular surface pathologies are the most common source of
eye discomfort and pain. Other pathological processes in-
volving inflammation of the uveal tract, like uveitis, acute
congestive glaucoma, retinitis, or endophthalmitis also
course with intense pain. The contribution of the different
functional types of ocular sensory nerve fibers to pain in
the posterior segment of the eye has not been defined in
detail, although polymodal nociceptors seem to play a
leading role in pain evoked by uveal stimulation [87, 88].
Pain and discomfort accompanying ocular surface
pathologies arise from a variable combination of inflam-
mation and nerve damage (Fig. 2), which influence mutually
and change in each particular pathological condition [89].
Disturbances in the architecture and molecular signature of
peripheral sensory nerves, TG somata, and synaptic con-
nections of the brain projection neurons are thus different
depending on the type of ocular surface disease. This
explains the variable alteration of the impulse activity at the
sensory nerve pathways in each case and thereby, the
quantitative and qualitative differences between unpleasant
eye sensations experienced in each ocular surface pathology.
Allergic conjunctivitis is primarily characterized by
tissue inflammation accompanied by itching, grittiness, and
burning of the eyes [90]. Recording of the various classes
of corneal nerve terminals in an experimentally induced
guinea pig model of allergic conjunctivitis [91] showed a
reduced threshold of mechano- and polymodal nociceptors
(i.e., these fibers responded to lower stimulus intensities);
moreover, impulse response of polymodal nociceptors to
noxious chemical stimuli was enhanced, altogether re-
flecting sensitization. In contrast, low-threshold cold ther-
moreceptor activity was depressed as it could be expected
from the inhibition of TRPM8 by inflammatory mediators
[65••]. Collectively, the overall changes in the firing re-
sponse of corneal sensory fibers correlate well with the
foreign body and itching sensations reported by allergic
kerato-conjunctivitis patients. A similar, altered pattern of
activity in nociceptors and cold thermoreceptors innervat-
ing the guinea pig eye surface was obtained after induction
of an experimental, actinic kerato-conjunctivitis [92] which
corresponds well with the subjective discomfort feelings
reported by these patients.
Unpleasant dryness sensations are possibly the most
prominent symptom in dry eye disease (DED) [93]. The
initial physical stimuli for ocular surface receptors in
aqueous-deficient and evaporative dry eye are evaporation-
induced enhanced cooling and augmented osmolality, two
potent activators of cold thermoreceptors [41••, 54••]. The
scenario complicates later, with the apparition of inflam-
mation and nerve damage resulting of the sustained dry-
ness-induced injury of eye surface epithelium cells [94, 95]
which affects polymodal nociceptors. In an experimental
model of chronic dry eye produced by removal of the main
lachrymal gland in guinea pigs [96], the discrete inflam-
mation developed during the 1st week following surgery
caused a moderate and transient sensitization of polymodal
nociceptors. When inflammation subsided, polymodal no-
ciceptors recovered in a great extent their normal behavior
as occurs with mechano-nociceptors. In contrast, along the
1st month after removal of the lacrimal gland, guinea pig
and mice cold thermoreceptors increase gradually their
ongoing activity, in parallel with a progressive alteration of
the morphological appearance of sensory fibers of the
cornea, suggestive of nerve damage [96, 97••]. This en-
hanced ongoing activity is due to an augmented expression
in corneal cold thermoreceptor neurons of Nav channels
together with a reduced expression of Kv channels, which
jointly induce a net increase in neuronal excitability [96].
The similarity of the functional changes seen in ocular cold
thermoreceptor neurons during dry eye, with those caused
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by oxaliplatin, a neurotoxic chemotherapy agent which
provokes neuropathy of cutaneous nerves and cold allo-
dynia [98], further suggests that nerve injury is, at least
partly behind the functional disturbances seen in cold
thermoreceptors following chronic eye dryness, addition-
ally enhanced by the stimulating effects of tear hyperos-
molality [54••]. Such augmented activity could evoke the
characteristic unpleasant sensations typical of DED, whose
conscious ‘dryness’ quality resembles the feelings experi-
enced in normal life when the intact eye surface is desic-
cated by strong air currents or low environmental humidity
[99]. In more severe forms of DED, local corneal surface
inflammation potentiated by the presence of inflammatory
mediators in secreted tears [95, 100•, 101], expectedly
activates also polymodal nociceptors, evoking additional
sensations of burning pain.
Photorefractive surgery is often accompanied by dis-
comfort sensations described as ‘eye dryness’ in spite of the
absence in most of these patients of a reduced tearing [102•].
In the different surgical procedures employed for this sur-
gical treatment, corneal sensory nerve endings are injured in
a variable degree [103]. Damage impairs the transducing
mechanisms and accordingly, polymodal and mechanosen-
sory fibers innervating the injured area respond less to natural
stimuli [104•]. In contrast, part of the cold thermoreceptors
around the wounded area exhibits an abnormally augmented
background activity and warmer thresholds for cooling. The
damaging effects on polymodal and mechanonociceptor
fibers explain the long-lasting reduction of mechanical and
chemical sensitivity observed in post- photorefractive sur-
gery patients [75••], whereas the presence of a ‘neuropathic’
activity in the injured corneal fibers would be the reason that
discomfort after photorefractive surgery is qualitatively de-
scribed as ‘dryness’ [105••].
Fig. 2 Schematic representation of the hypothetical influence of
injury and inflammation on sensory terminals of TG neurons
innervating the ocular surface. Inflammation activates directly and/
or sensitizes polymodal nociceptor fibers, causing inflammatory pain
while if these fibers are injured, they produce an abnormal, ectopic
ongoing activity evoking neuropathic pain. Nerve injury induces on
low-threshold cold thermoreceptors (LT) an abnormally high basal
ongoing activity that elicits sensations of dryness with a cooling
component; when high-threshold cold thermoreceptors (HT) become
spontaneously active, unpleasant or painful dryness sensations are
evoked. Contrarily, inflammation alone tends to silence TRPM8-
dependent impulse activity in both subtypes of cold thermoreceptors
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damage of nerve terminals and
local inflammation. Local
inflammation will further
activate and sensitize sensory
nerve fibers. These will evoke
discomfort and pain, reflex
effects and neurogenic
inflammation
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The influence of contact lens wearing on ocular surface
sensations and the psychophysical attributes of discomfort
sensations accompanying contact lens wearing has been
extensively studied in humans [106••]. Nevertheless, direct
knowledge of how contact lenses act on the peripheral and
central neural mechanisms underlying sensations arising
from eye tissues is lacking. Hypothetically, contact lenses
and solutions used for rinsing and disinfection may act as
mechanical and chemical stimulating forces for the cornea,
bulbar conjunctiva, palpebral conjunctiva, and eyelid bor-
ders, thus becoming potential activators of their sensory
nerve terminals. Lens wearing may additionally evoke with
time, variable levels of inflammation, and/or nerve terminal
injury in these tissues (Fig. 3). Direct stimulation of sen-
sory nerve fibers by the contact lens is expected to activate
a fraction of the various functional populations of sensory
nerve fibers innervating the eyeball and lids, including
nociceptors. Their activity will change with the develop-
ment of local inflammation around nerve terminals and
cause eventual nerve damage, as occurs in other ocular
surface aggressions, leading to augmented discomfort and
pain and reflex effects as vasodilation, increased tearing
and blinking. Inflammation can be amplified further
through neuropeptide release by the activated peptidergic
nerve terminals [106••]. However, in contrast with the
knowledge obtained for photorefractive surgery or eye
dryness, no experimental data are available about the type
of nerve fibers activated by the lens in the different eye
tissues, the temporal evolution of their activity with con-
tinued lens use and the contribution of inflammation and
nerve injury to impulse activity in the stimulated functional
types of sensory receptors. The absence of information on
these questions is surprising, considering its potential im-
portance for the design of new lenses and materials aimed
at alleviating discomfort caused by contact lens wearing
and deserves experimental attention. Figure 3 represents
schematically the hypothetical actions of contact lenses and
contact lens solutions on sensory nerve fibers of the ocular
surface, which would lead to nerve activation and the
corresponding sensory, reflex and inflammatory responses.
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